Eton Pharmaceutcials, Inc. Common Stock

ETONNASDAQUSD
64.43 USD
0.96 (1.51%)AT CLOSE (11:59 AM EDT)
65.19
0.75 (1.17%)
POST MARKET (AS OF 07:53 PM EDT)
Post Market
AS OF 07:53 PM EDT
65.19
0.75 (1.17%)
🔴Market: CLOSED

Eton Pharmaceutcials, Inc. Common Stock (ETON) trades at $64.38 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, exceptional Return on Equity (27.2%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, ETON is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Aug 24, 2026.

Open?$63.90
High?$66.37
Low?$62.90
Prev. Close?$63.47
Volume?801.5K
Avg. Volume?667.6K
VWAP?$64.74
Rel. Volume?1.20x
Bid / Ask
Bid?$63.70 × 100
Ask?$66.67 × 200
Spread?$2.97
Midpoint?$65.19
Valuation & Ratios
Market Cap?1.8B
Shares Out?28.6M
Float?23.9M
Float %?87.1%
P/E Ratio?145.15
P/B Ratio?39.53
EPS?$0.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Employees
44
Market Cap
1.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-11-14
Address
21925 W. FIELD PARKWAY
DEER PARK, IL 60010-7278
Phone: (847) 787-7361
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
100
Momentum?
85
Short Sent.?
50
Piotroski F-Score?4/9Mixed
Altman Z-Score?16.14Safe
Confidence?59%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.50%Elevated
Short Interest?1.3M
Days to Cover?2.1
Free Float23.9M
Avg Daily Volume633.1K
Settlement Date2026-07-31
Financial Health
Current Ratio?1.52Adequate
Quick Ratio?1.30Adequate
Cash Ratio?0.59Adequate
Debt/Equity?0.60Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
33/100
P/E?
Peers
100
S&P
3
145.2PRICEY
P/B?
Peers
100
S&P
3
39.53HIGH
P/S?
Peers
100
S&P
3
17.44HIGH
P/FCF?
Peers
100
S&P
3
125.0PRICEY
EV/EBITDA?
Peers
100
S&P
3
88.4HIGH
EV/Sales?
Peers
100
S&P
3
17.45HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
76
27.2%STRONG
ROA?
Peers
50
S&P
77
11.0%STRONG
Cash Flow & Enterprise
FCF?$14.7M
Enterprise Value?$1.8B
Fundamentals ratios updated end of day